Bispecific antibody-producing hybrid hybridomas selected by a fluorescence activated cell sorter
- PMID: 2433353
- DOI: 10.1016/0022-1759(87)90323-1
Bispecific antibody-producing hybrid hybridomas selected by a fluorescence activated cell sorter
Abstract
Hybrid hybridomas (tetradomas) producing bispecific monoclonal antibodies reacting with both horseradish peroxidase (HRP) and human alpha-fetoprotein (AFP) were obtained by fusing two hybridoma lines and selecting the fused cells by a fluorescence activated cell sorter (FACS III). The hybridoma cells were labelled before fusion with fluorescein isothiocyanate (FITC) and tetramethyl rhodamine isothiocyanate (TRITC) respectively and heterofluorescent cells were sorted out after fusion. Several clones were found to produce bispecific antibodies, and one clone, designated T1, was subjected to growth in ascitic fluid in mice in order to obtain large quantities of hybrid antibodies. Bispecific antibodies could be separated from the monospecific antibody populations by one-step hydroxylapatite chromatography. SDS-polyacrylamide gel electrophoresis demonstrated that the hybrid antibody molecules contained the heavy chains of both anti-HRP and anti-AFP origin. The bispecific antibodies were used to build up a sensitive two-site binding enzyme immunoassay.
Similar articles
-
Production and ELISA application of bispecific monoclonal antibodies against fluorescein isothiocyanate (FITC) and horseradish peroxidase (HRP).J Immunol Methods. 1988 Jun 28;111(1):95-9. doi: 10.1016/0022-1759(88)90064-6. J Immunol Methods. 1988. PMID: 2455756
-
Bispecific monoclonal antibodies to human interleukin 2 and horseradish peroxidase.Hybridoma. 1993 Jun;12(3):271-84. doi: 10.1089/hyb.1993.12.271. Hybridoma. 1993. PMID: 8359822
-
Flow sorting of hybrid hybridomas using the DNA stain Hoechst 33342.J Immunol Methods. 1990 May 25;129(2):277-82. doi: 10.1016/0022-1759(90)90448-5. J Immunol Methods. 1990. PMID: 2191045
-
Selection of hybridomas and hybridoma variants using the fluorescence activated cell sorter.J Immunol Methods. 1982;52(1):1-14. doi: 10.1016/0022-1759(82)90344-1. J Immunol Methods. 1982. PMID: 6811662 Review. No abstract available.
-
[Production of monoclonal antibodies and use of monospecific and monoclonal antibodies in immunochemical analyses].Fiziol Zh (1978). 1982 Jul-Aug;28(4):477-85. Fiziol Zh (1978). 1982. PMID: 6749561 Review. Russian. No abstract available.
Cited by
-
Universal bispecific antibody for targeting tumor cells for destruction by cytotoxic T cells.Proc Natl Acad Sci U S A. 1988 Oct;85(20):7719-23. doi: 10.1073/pnas.85.20.7719. Proc Natl Acad Sci U S A. 1988. PMID: 3140243 Free PMC article.
-
Bispecific antibodies: design, therapy, perspectives.Drug Des Devel Ther. 2018 Jan 22;12:195-208. doi: 10.2147/DDDT.S151282. eCollection 2018. Drug Des Devel Ther. 2018. PMID: 29403265 Free PMC article. Review.
-
Bispecific antibody: a tool for diagnosis and treatment of disease.Clin Exp Immunol. 1990 Mar;79(3):315-21. doi: 10.1111/j.1365-2249.1990.tb08089.x. Clin Exp Immunol. 1990. PMID: 2180597 Free PMC article. Review.
-
Therapeutic effect of ansamitocin targeted to tumor by a bispecific monoclonal antibody.Jpn J Cancer Res. 1992 Jul;83(7):761-8. doi: 10.1111/j.1349-7006.1992.tb01977.x. Jpn J Cancer Res. 1992. PMID: 1517150 Free PMC article.
-
A bispecific monoclonal antibody against methotrexate and a human tumour associated antigen augments cytotoxicity of methotrexate-carrier conjugate.Br J Cancer. 1990 Apr;61(4):508-13. doi: 10.1038/bjc.1990.115. Br J Cancer. 1990. PMID: 2331436 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources